Company / Shareholders' Equity
Beneficient Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$192.1M
FY2025
5-year range
-$192.1M / $1.7B
FY2023-FY2025
Trend
-111.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Beneficient reports negative total equity of -$192M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$192M in FY2025.
Declined from $992M to -$192M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 111.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -23.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$192.1M | -111.1% |
| FY2024 | $1.7B | +74.3% |
| FY2023 | $991.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026